Ultrapar Holdings Inc 6-K, filed Aug 2, 2022
Ultrapar Holdings Inc (UGP)
About this 6-K
Ultrapar Holdings Inc filed this 6-K on August 2, 2022.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
Form 6-K |
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 Or 15d-16 Of
The Securities Exchange Act Of 1934
For the month of August 2022
Commission File Number: 001-14950
ULTRAPAR HOLDINGS INC.
(Translation of Registrant’s Name into English)
Brigadeiro Luis Antonio Avenue, 1343, 9th Floor
São Paulo, SP, Brazil 01317-910
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ____X____ Form 40-F ________
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes ________ No ____X____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes ________ No ____X____
ULTRAPAR PARTICIPAÇÕES S.A.
Closing of the sale of Extrafarma
São Paulo, August 1, 2022 – Ultrapar Participações S.A. (B3: UGPA3 / NYSE: UGP, “Ultrapar” or “Company”), in addition to the material notice of May 18, 2021 and the market announcement of June 22, 2022, announces the conclusion of the sale of Extrafarma to Pague Menos S.A.
Pursuant to the Share Purchase Agreement, the total amount of R$ 700,000,000.00 was adjusted by the variations in working capital and net debt position of R$ 37,752,320.94, resulting in the total amount of R$ 737,752,320.94. This amount is still subject to final working capital and net debt adjustments. Out of the first installment of R$ 372,324,136.27, R$ 365,428,184.68 were paid by Pague Menos on the present date and R$ 6,895,951.59 were paid in cash by the shareholders who exercised the preemptive rights. The payment of the two remaining installments of R$ 182,714,092.34 each will be made in August 2023 and August 2024 by Pague Menos.
Consistent with the information that the Company has been providing to its shareholders and to the capital markets, with the sale of Extrafarma, Ultrapar concludes the process of rationalizing its portfolio and starts to focus its efforts on more complementary and synergistic businesses.
Rodrigo de Almeida Pizzinatto
Chief Financial and Investor Relations Officer
Ultrapar Participações S.A.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: August 1, 2022
| ULTRAPAR HOLDING INC. | |
|
By: /s/ Rodrigo de Almeida Pizzinatto |
|
|
Name: Rodrigo de Almeida Pizzinatto |
|
|
Title: Chief Financial and Investor Relations Officer |
(Market announcement)